Group One Trading, L.P. Eloxx Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

  • $3.01 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.24 - $0.58 $18,892 - $45,655
-78,717 Reduced 99.77%
179 $0
Q1 2022

May 12, 2022
BUY
$0.4 - $0.72 $13,649 - $24,569
34,124 Added 76.22%
78,896 $44,000
Q4 2021

Feb 11, 2022
BUY
$0.62 - $1.61 $27,758 - $72,082
44,772 New
44,772 $31,000

About Eloxx Pharmaceuticals, Inc.

ELOX Quotes by TradingView
  • Ticker ELOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,656,200
  • Description
  • Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...
More about ELOX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email